The biomarker N-terminal pro-brain natriuretic peptide and liver diseases

Clinical and Investigative Medicine

Volumn 34, Issue 1, 2011, Pages

  Wang, Ling ^a   Geng, Jiabao ^a,c   Li, Jie ^a   Li, Tong ^a   Matsumori, Akira ^b   Chang, Yibin ^a   Lu, Fengmin ^a   Zhuang, Hui ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b KYOTO UNIVERSITY   (Japan)

^c The 81st Hospital of PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TUMOR; MALE; MIDDLE AGED;

ADULT; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; YOUNG ADULT;

EID: 79951704125     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Porter JG, Arfsten A, Palisi T, Scarborough RM, Lewicki JA, Seilhamer JJ. Cloning of a cDNA encoding porcine brain natriu-retic peptide. J Biol Chem 1989;264:6689-6692 (Pubitemid 19114772)
2. Han B, Hasin Y. Cardiovascular effects of natriuretic peptides and their interrelation with endothelin-1. Cardiovasc Drugs Ther 2003;17:41-52 (Pubitemid 36898097)
3. Seilhamer JJ, Arfsten A, Miller JA, Lundquist P, Scarborough RM, Lewicki JA, Porter JG. Human and canine gene homologs of porcine brain natriuretic peptide. Biochem Biophys Res Commun 1989;165:650-658 (Pubitemid 20025571)
4. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jou- gasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K. Localization and mechanism of secretion of B-type natriuretic pep- tide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203 (Pubitemid 24203680)
5. Ruskoaho H, Leskinen H, Magga J, Taskinen P, Mantymaa P, Vuolteenaho O, Leppaluoto J. Mechanisms of mechanical load- induced atrial natriuretic peptide secretion: role of endothelin, nitric oxide, and angiotensin II. J Mol Med 1997;75:876-885 (Pubitemid 27511564)
6. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997;96:509-516 (Pubitemid 27329427)
7. Davidson NC, Naas AA, Hanson JK, Kennedy NS, Coutie WJ, Struthers AD. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 1996;77:828-831
8. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriu- retic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf) 1997;47:287-296 (Pubitemid 27395959)
9. Bay M, Kirk V, Parner J, Hassager C, Nielsen H, Krogsgaard K, Trawinski J, Boesgaard S, Aldershvile J. NT-proBNP: a new diagnostic screening tool to diferentiate between patients with normal and reduced left ventricular systolic function. Heart 2003;89:150-154 (Pubitemid 36115095)
10. Seino Y, Ogawa A, Yamashita T, Fukushima M, Ogata K, Fuku- moto H, Takano T. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail 2004;6:295-300 (Pubitemid 38253048)
11. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Ka- zanegra R, Herrmann HC, McCullough PA. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167 (Pubitemid 34764819)
12. Richards AM, Doughty R, Nicholls MG, MacMahon S, Sharpe N, Murphy J, Espiner EA, Frampton C, Yandle TG. Plasma N- terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic let ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol 2001;37:1781-1787 (Pubitemid 32499959)
13. Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, Hartford M, Caidahl K. N-terminal pro-B-type natriuretic pep- tide and long-term mortality in acute coronary syndromes. Circulation 2002;106:2913-2918 (Pubitemid 35424741)
14. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-1130 (Pubitemid 30172933)
15. Richards AM, Cohn JN. N-Terminal Pro-Brain Natriuretic Pep- tide: A Powerful Biomarker of Cardiac Disease. J Card Fail 2005;11:S1-S2
16. Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003;107:2545-2547 (Pubitemid 36628932)
17. Pruszczyk P, Kostrubiec M, Bochowicz A, Styczynski G, Szulc M, Kurzyna M, Fijalkowska A, Kuch-Wocial A, Chlewicka I, Torbicki A. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur Respir J 2003;22:649-653 (Pubitemid 37258545)
18. Kucher N, Printzen G, Doernhoefer T, Windecker S, Meier B, Hess OM. Low pro-brain natriuretic peptide levels predict be-nign clinical outcome in acute pulmonary embolism. Circulation 2003;107:1576-1578 (Pubitemid 36397323)
19. Talwar S, Siebenhofer A, Williams B, Ng L. Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP. Heart 2000;83:278-282 (Pubitemid 30313329)
20. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hilde- brandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. Jama 2005;293:1609-1616 (Pubitemid 40471791)
21. Matsumori A, Shimada T, Chapman NM, Tracy SM, Mason JW. Myocarditis and heart failure associated with hepatitis C virus infection. J Card Fail 2006;12:293-298
22. [Guideline of prevention and treatment of hepatitis C]. Zhonghua Yu Fang Yi Xue Za Zhi 2004;38:210-215
23. [The guideline on the prevention and treatment of chronic liver diseases]. Zhong Hua Gan Zang Bing Za Zhi 2005;13:881-891
24. Nir A, Bar-Oz B, Perles Z, Brooks R, Korach A, Rein AJ. N- terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr 2004;93:603-607 (Pubitemid 38570224)
25. Koch A, Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 2003;89:875-878 (Pubitemid 36920810)
26. Kunii Y, Kamada M, Ohtsuki S, Araki T, Kataoka K, Kageyama M, Nakagawa N, Seino Y. Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 2003;57:191-197 (Pubitemid 37386876)
27. de Lemos JA, Hildebrandt P. Amino-terminal pro-B-type natriuretic peptides: testing in general populations. Am J Cardiol 2008;101:16-20
28. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Ras- mussen S, Wachtell K, Borch-Johnsen K, Ibsen H, Jorgensen T, Hildebrandt P. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 2005;46:660-666 (Pubitemid 43186736)
29. Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodeheffer RJ, Urban LH, Mahoney DW, Jacobsen SJ, Heublein DM, Burnett JC, Jr. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 2006;47:345-353 (Pubitemid 43063253)
30. Galasko GI, Lahiri A, Barnes SC, Collinson P, Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? Eur Heart J 2005;26:2269-2276 (Pubitemid 41541390)
31. Bernal V, Pascual I, Esquivias P. Cirrhotic Cardiomyopathy: An Overall Assessment and Role of NT-proBNP. Gastroenterology 2009;136:A-796
32. Bettencourt P, Januzzi JL, Jr. Amino-terminal pro-B-type natriu- retic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure. Am J Cardiol 2008;101:67-71